Overview

A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults

Status:
Not yet recruiting

Trial end date:
2023-06-05

Target enrollment:

Participant gender:

Summary

This is a Phase 1, open-label, fixed-sequence, 3-period study to evaluate the effect of multiple doses of itraconazole and a single dose of cyclosporine on the single-dose PK of PF-07081532 in otherwise healthy, overweight or obese, adult female and male participants. The 3 study periods will be conducted consecutively without a break.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Cyclosporine
Cyclosporins
Itraconazole